NCT05441449

Brief Summary

Persons with higher levels of spinal cord injury (above the 6th thoracic vertebrae: Hi-SCI) are unable to maintain their core body temperature (Tcore) within the normal range (97.5-99.7 °F) when exposed to warm environments. Even limited exposure to warm temperatures can cause hyperthermia (Tcore 100.4°F) in Hi-SCI. Mild hyperthermia causes discomfort and impaired thinking, but if unchecked, can lead to permanent damage to the brain, multiple body organ failure, and death. Warm seasonal temperatures have an adverse effect on personal comfort and the ability to participate in daily social activities in persons with Hi-SCI. Interventions addressing this vulnerability to hyperthermia are limited. A self-regulating "smart" cooling vest designed for persons with Hi-SCI, that can effectively dissipate body heat, is a novel and promising strategy to address this problem. Once the current prototype is further developed and bench-tested, the investigators will test the vest in able-bodied participants for safety and comfort. The investigators will then test the vest in participants with Hi-SCI for efficacy. The aim for the cooling vest to minimize the expected increase of 1.1°F in Tcore by at least 50 percent and increase thermal comfort, during a controlled exposure to heat (95°F). If successful, the vest will provide a promising intervention to decrease the adverse impact of warm temperatures on comfort, quality of life, and participation in societal functions for Veterans with Hi-SCI during the warmer seasons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 16, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 1, 2022

Completed
1.5 years until next milestone

Study Start

First participant enrolled

December 18, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
2 months until next milestone

Results Posted

Study results publicly available

April 15, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

June 16, 2022

Results QC Date

March 26, 2025

Last Update Submit

April 14, 2025

Conditions

Keywords

Body Temperature RegulationHyperthermiaBody Temperature

Outcome Measures

Primary Outcomes (2)

  • Skin Temperature (Tsk) Change

    Tsk will be monitored using TX-4 Skin Surface probes and Iso-Thermex Multichannel Thermometer (Columbus Instruments, Columbus, OH). Skin thermocouples will be taped to 12 sites on the trunk (chest/abdomen) of AB controls (6 on each side) and on 10 sites on the chest/abdomen (5 on each side) and 4 sites on the bilateral hands and feet (2 on each side) for a total of 14 sites on persons with Hi-SCI determine change and minimum skin temperatures beneath the cooling vest

    Baseline (0 min) and end of thermal challenge (120 min) will be compared

  • Thermal Sensation (TS) Change

    TS will be measured by a 9-point (+4 to -4) thermal sensation scale (+4 Very Hot. +3 Hot, +2 Warm, +1 Slightly Warm, 0 Neutral, -1 Slightly Cool, -2 Cool, -3 Cold, -4 Very Cold). During a thermal challenge, a subjective score of "0" (Neutral) would be preferred as it indicates thermoregulatory mechanisms are effective for the participant.

    Baseline (0 min) and end of thermal challenge (120 min) will be compared

Secondary Outcomes (2)

  • Core Body Temperature (Tcore) Change

    Baseline (0 min) and end of thermal challenge (120 min) will be compared in persons with Hi-SCI

  • Thermal Comfort (TC) Change

    Baseline (0 min) and end of thermal challenge (120 min) will be compared in persons with Hi-SCI

Study Arms (3)

Arm 1: Cooling Vest

EXPERIMENTAL

Phase 1: After satisfying bench testing criteria, AB participants will wear the wet cooling vest at maximal settings for 2 hours in the seated position in a warm thermal chamber (35°C), to determine: (1) minimum skin temperatures beneath the cooling vest and (2) subjective thermal sensation of their skin beneath the cooling vest.

Device: Cooling Vest

Arm 2: Cooling Vest

EXPERIMENTAL

Phase 2: Participants with Hi-SCI will wear the wet vest (experimental condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.

Device: Cooling Vest

Arm 3: No Vest

NO INTERVENTION

Phase 2: Participants with Hi-SCI will wear no vest (control condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.

Interventions

A self-regulating cooling vest for persons with SCI that can utilize both conductive and evaporative methods to dissipate body heat as a proof-of-concept to prevent an excessive rise in Tcore and thermal discomfort during a controlled exposure to a warm environment. The vest is an article of clothing, is made of commercially-available "wicking" material, which once saturated with water, uses evaporation to dissipate heat. Channels embedded in the vest supply cooled water to keep the wet vest cool. The cooling capacity of the vest is regulated by a microprocessor which continuously receives feedback from the user's skin and core temperature. The vest is non-invasive and supplies no energy to the user.

Also known as: Novel Cooling Vest
Arm 1: Cooling VestArm 2: Cooling Vest

Eligibility Criteria

Age18 Years - 68 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal cord injury (SCI) \>1 year in duration
  • Level of SCI C4-T2, ASIA Impairment Scale A \& B
  • Gender and age-matched (±5 years) able-bodied (AB) controls
  • Euhydration (participants will be instructed to avoid caffeine and alcohol, maintain normal salt and water intake and avoid strenuous exercise for 24 hours prior to study)

You may not qualify if:

  • Known cardiovascular, kidney or untreated thyroid disease
  • Traumatic brain injury (mod-severe)
  • Diabetes mellitus
  • Acute illness or infection
  • Broken, inflamed, or otherwise fragile skin
  • Pregnancy
  • BMI \>30 kg/m2
  • Smoking Participants with SCI only (secondary to telemetry capsule (CorTemp®) measurement of Tcore)
  • Undergoing magnetic resonance imaging while the telemetry capsule is within the body (2-5 days)
  • Cardiac pacemaker or other implanted electromedical device
  • Known or suspected obstructive disease of the GI tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James J. Peters VA Medical Center, Bronx, NY

The Bronx, New York, 10468-3904, United States

Location

Related Links

MeSH Terms

Conditions

Spinal Cord InjuriesHyperthermia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsHeat Stress Disorders

Results Point of Contact

Title
Dr. John Handrakis
Organization
Spinal Cord Damage research Center, James J. Peters VA Medical Center

Study Officials

  • John Philip Handrakis, PT DPT EdD

    James J. Peters Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
FACTORIAL
Model Details: After the cooling vest has been fully bench-tested, two phases (AB safety; SCI efficacy) will be performed. Phase 1 (Safety): Descriptive design: because persons with SCI have impaired sensation, one group of able-bodied (AB) participants will wear the wet "smart" cooling vest during a heat challenge (sitting in a warm room) to determine its safety. Phase 2 (Efficacy): 1 x 2 Repeated Measures design: one group of persons with Hi-SCI will undergo 2 heat challenges (sitting in a warm room) under 2 conditions (experimental: wet vest, control: no vest) in random order to determine efficacy of the cooling vest in maintaining Tcore and thermal comfort..
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 16, 2022

First Posted

July 1, 2022

Study Start

December 18, 2023

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

April 30, 2025

Results First Posted

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

A de-identified data set will be shared with the public. Age and SCI level along with all other 18 HIPAA identifiers will be withheld. This data will be shared under an agreement that does not allow re-identification of the data set.

Locations